Well, if your assumption is right GROK says this about

New Post Public Reply Private Reply Replies (1) Message Board
manfromjax Poseidon360 #32919
365
Well, if your assumption is right GROK says this about shareprice

Estimating the share price valuation for Verb Technology Company, Inc. (VERB) if Q1 2025 revenue surpasses $723,000 involves analyzing available financial data, market dynamics, and valuation metrics. Below is a detailed assessment based on current information and reasonable assumptions, acknowledging the speculative nature of such projections due to limited specific guidance and market volatility.
Key Data Points
Q4 2024 Revenue: $723,000, with total 2024 revenue of $895,000 (1,321% year-over-year growth).

Current Stock Price: Approximately $4.41 as of April 24, 2025, with a market cap of $4.91 million (1,113,143 shares outstanding).

Price-to-Sales (P/S) Ratio: Based on 2024 revenue of $895,000 and a market cap of $4.93 million as of March 11, 2025, the trailing P/S ratio is approximately 5.51 ($4.93M / $0.895M).

Analyst Revenue Forecast for 2025: $1,191,685 annually, implying ~$297,921 per quarter if evenly distributed, though Verb expects to exceed Q4 2024’s $723,000 in Q1 2025.

Recent Performance: Q4 2024 revenue grew 465% quarter-over-quarter from $128,000 in Q3 2024. Strategic initiatives (MARKET.live, Go Fund Yourself, LyveCom acquisition, telehealth vertical) are expected to drive further growth.

Balance Sheet: $15.8 million in cash and investments, $18.03 million in stockholder equity as of Q3 2024, supporting growth initiatives.

Price-to-Book (P/B) Ratio: 0.31 as of Q4 2024, suggesting potential undervaluation relative to assets.

Analyst Price Target: One analyst suggests a 12-month target of $800.00, though this appears speculative and inconsistent with current metrics.

Revenue Scenarios for Q1 2025
Since Verb expects Q1 2025 revenue to surpass $723,000, let’s consider two plausible scenarios based on historical growth trends and strategic developments:
Conservative Scenario: Revenue of $800,000, a 10.5% increase from Q4 2024, reflecting steady growth from MARKET.live ($490,000 in Q4), Go Fund Yourself ($233,000 in Q4), and contributions from LyveCom and telehealth.

Optimistic Scenario: Revenue of $900,000, a 24.5% increase, assuming accelerated growth from expanded marketing, new verticals, and synergies from the LyveCom acquisition completed in April 2025.

Valuation Approach
To estimate the share price, we’ll use the Price-to-Sales (P/S) ratio, a common metric for high-growth, pre-profit tech companies like Verb, and cross-check with the Price-to-Book (P/B) ratio to assess asset-based valuation. We’ll also consider market sentiment and qualitative factors.
1. P/S-Based Valuation
Current P/S Ratio: 5.51, based on 2024 revenue and market cap.

Assumption: The market may maintain a similar P/S ratio or increase it slightly (e.g., to 6.0–7.0) if Q1 2025 results exceed expectations, reflecting optimism about Verb’s growth trajectory.

Step 1: Estimate Annualized Revenue
For Q1 2025 revenue of $800,000, assume steady performance across quarters, leading to annualized revenue of ~$3.2 million ($800,000 × 4).

For Q1 2025 revenue of $900,000, annualized revenue is ~$3.6 million ($900,000 × 4).

Step 2: Calculate Market Cap
Conservative Scenario ($800,000 Q1 revenue):
At P/S = 5.51: Market cap = $3.2M × 5.51 = $17.63 million.

At P/S = 6.0: Market cap = $3.2M × 6.0 = $19.2 million.

At P/S = 7.0: Market cap = $3.2M × 7.0 = $22.4 million.

Optimistic Scenario ($900,000 Q1 revenue):
At P/S = 5.51: Market cap = $3.6M × 5.51 = $19.84 million.

At P/S = 6.0: Market cap = $3.6M × 6.0 = $21.6 million.

At P/S = 7.0: Market cap = $3.6M × 7.0 = $25.2 million.

Step 3: Calculate Share Price
Shares outstanding: 1,113,143.

Share price = Market cap ÷ Shares outstanding.

Conservative Scenario:
P/S = 5.51: $17.63M ÷ 1,113,143 = ~$15.84.

P/S = 6.0: $19.2M ÷ 1,113,143 = ~$17.25.

P/S = 7.0: $22.4M ÷ 1,113,143 = ~$20.12.

Optimistic Scenario:
P/S = 5.51: $19.84M ÷ 1,113,143 = ~$17.83.

P/S = 6.0: $21.6M ÷ 1,113,143 = ~$19.41.

P/S = 7.0: $25.2M ÷ 1,113,143 = ~$22.64.

2. P/B-Based Valuation
Current P/B Ratio: 0.31, with stockholder equity of $18.03 million as of Q3 2024.

Book Value per Share: $18.03M ÷ 1,113,143 = ~$16.20.

Current Share Price: $4.41, implying the market significantly discounts Verb’s assets, possibly due to profitability concerns or market skepticism.

If Q1 2025 revenue surpasses $723,000, positive market sentiment could push the P/B ratio closer to 1.0 (typical for tech firms with growth potential):
At P/B = 0.5: Share price = $16.20 × 0.5 = ~$8.10.

At P/B = 0.75: Share price = $16.20 × 0.75 = ~$12.15.

At P/B = 1.0: Share price = $16.20 × 1.0 = ~$16.20.

3. Analyst and Market Sentiment
Analyst Price Target: One analyst’s $800.00 target seems unrealistic given current financials and market cap, likely reflecting speculative enthusiasm rather than fundamentals.

Recent Stock Performance: Despite Q4 2024’s strong revenue, the stock fell 8.41% to $5.01 in aftermarket trading, suggesting investor caution or profit-taking.

X Sentiment: A post on May 9, 2025, suggested short-term price targets of $6.43, $7.60, and $9.36, indicating some bullish sentiment among traders.

Market Dynamics: Verb’s low float (<800,000 shares post-split) and history of volatility (52-week range: $3.81–$40.30) suggest potential for significant price swings if Q1 2025 results exceed expectations.

Critical Analysis
Bullish Factors:
Strong revenue growth (465% Q3 to Q4 2024) and diversified streams (MARKET.live, Go Fund Yourself, telehealth, LyveCom) support the expectation of surpassing $723,000.

A low P/B ratio (0.31) and high cash reserves ($15.8M) suggest undervaluation and financial stability, potentially attracting value investors.

Strategic partnerships (TikTok, Meta, Cheddar TV) and the LyveCom acquisition could enhance revenue and market perception.

Bearish Factors:
Persistent losses (Q4 2024 net loss: $3.19M, EPS: -$3.463 vs. -$2.52 estimate) and high cash burn raise concerns about profitability.

Analyst forecasts of a 2025 sales decline (to $1.19M annually) contrast with Verb’s optimism, creating uncertainty.

Recent stock price declines despite strong Q4 results indicate market skepticism or manipulation concerns (e.g., short-selling post-reverse split).

Risks: The micro-cap nature of Verb ($4.91M market cap) and high volatility (9.53%, beta 1.15) make it susceptible to sharp price movements. Failure to achieve profitability or execute on new verticals could cap upside.

Estimated Share Price Valuation
Combining P/S and P/B approaches with market sentiment:
Conservative Estimate ($800,000 Q1 revenue):
P/S-based (5.51–6.0): $15.84–$17.25.

P/B-based (0.75): $12.15.

Weighted estimate (favoring P/S due to growth focus): ~$14.00–$16.00.

Optimistic Estimate ($900,000 Q1 revenue):
P/S-based (6.0–7.0): $19.41–$22.64.

P/B-based (1.0): $16.20.

Weighted estimate: ~$18.00–$20.00.

Final Answer
If Verb Technology’s Q1 2025 revenue surpasses $723,000, the share price could reasonably be valued at:
$14.00–$16.00 in a conservative scenario (e.g., $800,000 revenue), reflecting steady growth and modest market optimism.

$18.00–$20.00 in an optimistic scenario (e.g., $900,000 revenue), assuming strong execution and improved sentiment.
These estimates assume no major market disruptions or negative earnings surprises (e.g., wider losses). Investors should monitor the May 20, 2025, earnings report for confirmation of revenue and profitability trends.


Disclaimer: This valuation is speculative and based on limited public data. Stock prices are influenced by unpredictable factors, including market sentiment, macroeconomic conditions, and company-specific risks. Always conduct independent research and consult financial advisors before investing.

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Protein Now! Gains Clinician Attention, With Caveats

Updated Category News Views 91

A Small Bottle Has Drawn a Crowd Protein powder tubs have been cluttering kitchens for years; a 3.38-fluid-ounce shot is a cleaner answer to the same daily hassle. NutraBio Labs says more than 800 physicians, nurse practitioners, and physician associates had added PROTEIN NOW! to their individual FrontrowMD patient pages as of November 2026. That earned the product a...

Continue Reading
Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 58

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 61

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading
Perigon Builds Its Investment Bench for the Next Leg

Updated Category News Views 110

Perigon is rearranging the engine room before the next growth spurt gets noisy. The firm has named Christopher Broderick Director of Investments and Research, added two trading associates, and put another brick behind the broader operating structure Rafia Hasan has been assembling since taking on the chief operating officer role in August. That may sound like ordinary...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 87

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 247

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 27

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 95

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
San Bernardino Teamsters Back Their Historic Contract

Updated Category News Views 61

A 90% vote does not whisper; it rattles the filing cabinets. More than 12,000 San Bernardino County members of Teamsters Local 1932 have ratified a new labor agreement with over 90% approval, according to the union’s November 20 announcement. In a public-sector negotiation, that kind of margin matters because it tells management the workforce is not merely accepting a...

Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition

Updated Category News Views 64

Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Medical REIT Declares Significant 2024 Dividend Payments

Updated Category News Views 100

Global Medical REIT Inc. Announces 2024 Dividend Declares In an exciting update for shareholders, Global Medical REIT Inc. (NYSE: GMRE) has announced its board's decision to declare the 2024 fourth quarter common and preferred dividends. This revelation underscores the company's commitment to returning value to its investors, especially as it continues its growth...

Continue Reading
Predictive Dialer Software Market Growth and Insights for Businesses

Updated Category News Views 247

Rising Demand and Forecast for Predictive Dialer Software The predictive dialer software market is on an impressive trajectory, moving from a valuation of USD 2.6 billion to a staggering USD 45.1 billion in the coming years. This remarkable growth is primarily fueled by the increasing demand for telemarketing solutions and the rising number of automated contact centers...

Continue Reading
RWE and GE Vernova Collaborate for Energy Projects in the U.S.

Updated Category News Views 217

RWE Strengthens Partnership with GE Vernova for Sustainable Energy RWE has taken a significant step in advancing renewable energy in the U.S. by selecting GE Vernova as its trusted supplier for over 100 domestically produced wind turbines. This strategic decision will support two major energy projects, contributing 308 MW to the renewable energy grid. In doing so, RWE...

Continue Reading
Olin Corporation Reports Fourth Quarter Financial Highlights

Updated Category News Views 210

Olin Corporation's Financial Overview In a recent report, Olin Corporation (NYSE: OLN) disclosed its financial performance for the fourth quarter, showcasing a net income of $10.7 million, translating to $0.09 per diluted share. This figure reflects a decline compared to a net income of $52.9 million, or $0.43 per diluted share, seen in the corresponding quarter of the...

Continue Reading
Converge Technology Solutions Adjusts Dividend Payment Date

Updated Category News Views 214

Converge Technology Solutions Adjusts Dividend Payment Schedule Converge Technology Solutions Corp. (TSX: CTS) is set to enhance its dividend distribution process by moving the payment date forward due to holiday timings. Originally planned for December 28, 2024, shareholders can now expect to receive their dividend one day earlier, on December 27, 2024. This adjustment...

Continue Reading